Utilico Insights - Jacqueline Broers assesses why Vietnam could be the darling of Asia for investors. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,707.60
Bid: 1,707.40
Ask: 1,707.80
Change: 2.40 (0.14%)
Spread: 0.40 (0.023%)
Open: 1,701.60
High: 1,709.60
Low: 1,699.40
Prev. Close: 1,705.20
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

25 Nov 2013 06:43

GlaxoSmithKline's Bird Flu Vaccine Gets FDA Approval

Read more
24 Nov 2013 15:02

CORRECTED-UPDATE 1-U.S. FDA approves GSK's bird flu vaccine for national stockpile

(Removes incorrect name Pandemrix, paragraph 2) By Toni Clarke Nov 22 (Reuters) - The U.S. Food and Drug Administration said on Friday it has approved a vaccine made by GlaxoSmithKline Plc for use in the event of an H5N1 bird flu epidemic. The vaccine will be added to the nation

Read more
22 Nov 2013 21:44

U.S. FDA approves GlaxoSmithKline's H5N1 bird flu vaccine

Nov 22 (Reuters) - The U.S. Food and Drug Administration said on Friday it has approved GlaxoSmithKline Plc's pandemic flu vaccine for use in the event of an H5N1 bird flu epidemic. The vaccine will be added to the national stockpile and will not be available for commercial use, the FDA sa

Read more
22 Nov 2013 16:36

UPDATE 2-Gilead and GSK drugs for HCV and HIV win EU green light

* EMA recommends Gilead's Sovaldi and GSK's Tivicay * Also backs Otsuka TB drug, Bristol/Astra diabetes pill * Gilead shares rise 4.7 percent LONDON, Nov 22 (Reuters) - European regulators have recommended approval of a new drug from Gilead Sciences to treat hepatitis C and an

Read more
22 Nov 2013 14:01

GlaxoSmithKline And ViiV Receive Positive CHMP In EU For HIV Treatment

Read more
22 Nov 2013 13:47

EU agency backs new drugs from GSK, Gilead, Otsuka

LONDON, Nov 22 (Reuters) - European regulators said on Friday they had recommended approval of a new drug for HIV from GlaxoSmithKline and a novel hepatitis C treatment from Gilead Sciences. The European Medicine Agency (EMA) also gave a green light to an Otsuka tuberculosis drug, following

Read more
22 Nov 2013 10:43

GlaxoSmithKline To Invest GBP25 Million To Expand Operations In Scotland

Read more
22 Nov 2013 07:24

Friday newspaper round-up: WTO, Serco, National Grid

Negotiators are poised to seal the first global trade deal for more than a decade, in a rare victory for the World Trade Organisation, whose struggle to secure an international pact has increasingly threatened its relevance. The US and powerful developing-nation players, including China and India, h

Read more
20 Nov 2013 11:33

London midday: Markets in the red with BoE, Fed in focus

- BoE voted unanimously on policy at last meeting - MPC attempts to play down rate-hike fears - Taper in focus ahead of FOMC minutes techMARK 2,627.20 -0.64% FTSE 100 6,670.70 -0.41% FTSE 250 15,181.39 -0.55% UK markets were trading in the red on Wednesday after the Bank of England expressed conce

Read more
20 Nov 2013 09:46

STOCKS NEWS EUROPE-MS picks European winners from China reforms

Europe's consumer, healthcare and technology companies should win out from the sweeping reforms in China, reckons Morgan Stanley, citing the commitment to a market economy, as well as the relaxation of the one child policy and the hukou household registration system. To capitalise on this,

Read more
20 Nov 2013 08:19

London open: Investors turn cautious ahead of FOMC minutes

- Bernanke comments in focus ahead of FOMC minutes - Telecom Plus buys back businesses from Npower - Diageo CEO warns of 'uncertain' global economy techMARK 2,637.85 -0.24% FTSE 100 6,687.39 -0.16% FTSE 250 15,243.72 -0.14% UK stocks declined on Wednesday as investors adopted a cautious approach a

Read more
20 Nov 2013 07:46

Glaxo Completes Aspen Stake Sale For GBP425 Million

Read more
20 Nov 2013 07:33

London pre-open: FTSE called to open lower ahead of Fed and BoE minutes

City sources predict the FTSE 100 will open around 21 points lower than yesterday's close of 6,698.01, ahead of the release of the minutes from both the Bank of England and the latest meeting of the US Federal Reserve. The Federal Open Market Committee's meeting should offer further insight behind

Read more
20 Nov 2013 07:11

GlaxoSmithKline completes sale of Aspen shares, raising $694 mln

LONDON, Nov 20 (Reuters) - GlaxoSmithKline said on Wednesday it had completed the sale of 28.2 million shares in Aspen Pharmacare at 250 rand each, raising gross proceeds of 7.059 billion rand ($694 million). Shares in the South African drugmaker closed at 267.40 rand on Tuesday. GSK

Read more
20 Nov 2013 07:03

GSK completes sale of stake in Aspen Pharmacare

GlaxoSmithKline (GSK) has completed the partial sale of Aspen Pharmacare, the drug company announced on Wednesday. The group has disposed 28.2m ordinary shares in Aspen at a price of 250 South African Rand (ZAR) per share, raising gross proceeds of 7,059m ZAR. The sale will leave GSK with 56.5m or

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.